News
Note from the MD: Census working overtime: One month out from critical survey and confusion abounds
We’re now about a month out from the next Australian census and no doubt the data collected will yield some interesting results this time around.
Note from the MD: Markets up after raucous first week of new financial year
Seven days into a new financial year and what a tumultuous week it’s been.
‘Huge tailwinds’ at play for micro investment platform Raiz
Dean Fergie from Cyan Investment Management selected 3 of his favourite stocks during a recent presentation for Reach Markets’ The Insider series. Raiz Invest Australia was one of them. All 3 company spokespersons were invited to join us to present…
Young money: Microcaps targeting millennial investors as market demographics shift
A new Millennial-focused investor conference has drawn mixed reactions from Australia’s financial gentry, despite data showing these young guns will play an increasingly important role in markets.
Steady revenues for Australian gaming industry as EOFY winds down
Australia’s blossoming video game industry is expecting a bright future after weathering the COVID storm with aplomb, a new report from the Interactive Games & Entertainment Association shows.
Puppies and parties and smokes, oh my! Aussies try pulling fast ones on the ATO
Taxes are one of life’s only two certainties – but for ATO staff reviewing Australia’s weird and wacky deductions claims, the contents of each new file to fall across their desk is anything but certain.
Prescient Therapeutics delivers positive immune response test results
Shares in biotech company, Prescient Therapeutics, have proved buoyant this week after initial immunogenicity testing demonstrated the company’s OmniCAR binding systems for next-generation CAR-T therapies are unlikely to trigger adverse reactions.
Note from the MD: End of financial year marks 12 months of sizeable gains
As June draws to a close, investors everywhere are wishing farewell to the best financial year on Australian markets in almost three and a half decades.
Prescient Completes CAR-T Manufacturing Milestone for Next Generation Immunotherapy Platform
Prescient Therapeutics (ASX: PTX) is pleased to announce the successful completion of the manufacturing and delivery of crucial components of the OmniCAR platform for Prescient’s in-house programs of next-generation CAR-T therapies.
Did Cristiano Ronaldo’s coke problem line the pockets of the US health industry?
Coca Cola’s decision to sponsor the Euro 2020 soccer tournament appeared to be an “own-goal” after star player, Cristiano Ronaldo, seemingly wiped US $4 billion off the company’s share price.
The future is pearly white for SDI
Senior Portfolio Manager, Stephen Scott from K2 Asset Management selected 3 of his favourite stocks during a recent presentation for Reach Markets’ The Insider series. SDI was one of them. All 3 company spokespersons were invited to join us to…
Nusantara receives $80 million takeover bid from Indonesian partner
ASX-listed gold explorer Nusantara has received a takeover bid from its largest shareholder, and local partner, Indika Energy.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.